Jackson Hole Capital Partners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$120K Hold
940
0.02% 234
2025
Q4
$115K Hold
940
0.02% 233
2025
Q3
$94.2K Hold
940
0.02% 235
2025
Q2
$78K Sell
940
-900
-49% -$71.8K 0.01% 229
2025
Q1
$149K Hold
1,840
0.03% 204
2024
Q4
$166K Hold
1,840
0.03% 203
2024
Q3
$182K Hold
1,840
0.04% 194
2024
Q2
$171K Hold
1,840
0.04% 196
2024
Q1
$175K Hold
1,840
0.04% 197
2023
Q4
$164K Hold
1,840
0.04% 195
2023
Q3
$134K Hold
1,840
0.04% 192
2023
Q2
$153K Hold
1,840
0.04% 200
2023
Q1
$140K Hold
1,840
0.04% 221
2022
Q4
$153K Hold
1,840
0.05% 188
2022
Q3
$146K Hold
1,840
0.04% 184
2022
Q2
$137K Buy
1,840
+400
+28% +$30K 0.04% 178
2022
Q1
$129K Hold
1,440
0.04% 184
2021
Q4
$161K Hold
1,440
0.05% 173
2021
Q3
$181K Hold
1,440
0.06% 179
2021
Q2
$195K Hold
1,440
0.07% 171
2021
Q1
$195K Hold
1,440
0.08% 162
2020
Q4
$203K Hold
1,440
0.09% 142
2020
Q3
$160K Hold
1,440
0.08% 130
2020
Q2
$161K Hold
1,440
0.1% 122
2020
Q1
$112K Buy
1,440
+150
+12% +$13.3K 0.08% 115
2019
Q4
$123K Hold
1,290
0.07% 148
2019
Q3
$98K Hold
1,290
0.06% 150
2019
Q2
$113K Hold
1,290
0.07% 145
2019
Q1
$117K Buy
1,290
+90
+8% +$7.66K 0.1% 123
2018
Q4
$86K Buy
+1,200
New +$96.7K 0.09% 119

Other funds holding XBI

Jackson Hole Capital Partners's XBI Position: Q1 2026 in Review

Jackson Hole Capital Partners held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q1 2026 at 940 shares worth $120K. The position accounts for 0.02% of the portfolio, ranked #234.

Jackson Hole Capital Partners first reported a position in XBI in Q4 2018 and has held it in 30 quarters since. The position peaked at $203K in Q4 2020. 814 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

  • Jackson Hole Capital Partners held 940 shares of State Street SPDR S&P Biotech ETF worth $120K as of Q1 2026.
  • Jackson Hole Capital Partners left its State Street SPDR S&P Biotech ETF share count unchanged in Q1 2026.
  • State Street SPDR S&P Biotech ETF made up 0.02% of Jackson Hole Capital Partners's portfolio in Q1 2026, its #234 holding.
  • Jackson Hole Capital Partners first reported a position in State Street SPDR S&P Biotech ETF in Q4 2018 and has held it in 30 quarters since.
  • Jackson Hole Capital Partners's State Street SPDR S&P Biotech ETF position peaked at $203K in Q4 2020.
  • 814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Jackson Hole Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.